CymaBay Therapeutics

YTD

ALL

Why Robinhood?

You can watch CBAY and buy or sell other stocks, ETFs, and their options commission-free!

About CBAY

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001.

CEO

Andrew D. Dickinson

CEOAndrew D. Dickinson

Employees

—

Employees—

Headquarters

Foster City, California

HeadquartersFoster City, California

Founded

1988

Founded1988

Employees

—

Employees—

CBAY Key Statistics

Market cap

3.73B

Market cap3.73B

Price-Earnings ratio

-32.75

Price-Earnings ratio-32.75

Dividend yield

—

Dividend yield—

Average volume

1.85M

Average volume1.85M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$32.50

52 Week high$32.50

52 Week low

$7.26

52 Week low$7.26

People also own

Based on the portfolios of people who own CBAY. This list is generated using Robinhood data, and it’s not a recommendation.

Edgio

Catalyst Pharmaceuticals